First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome

BACKGROUND AND OBJECTIVES: Children with multi-drug resistant idiopathic nephrotic syndrome (MDR-INS) usually progress to end-stage kidney disease with a consistent risk of disease recurrence after transplantation. New therapeutic options are needed for these patients. Mesenchymal stromal cells (MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Morello, William, Budelli, Silvia, Bernstein, Daniel Ari, Montemurro, Tiziana, Montelatici, Elisa, Lavazza, Cristiana, Ghio, Luciana, Edefonti, Alberto, Peruzzi, Licia, Molino, Daniela, Benetti, Elisa, Gianoglio, Bruno, Mehmeti, Florian, Catenacci, Laura, Rotella, Jessica, Tamburello, Chiara, Moretta, Antonia, Lazzari, Lorenza, Giordano, Rosaria, Prati, Daniele, Montini, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389735/
https://www.ncbi.nlm.nih.gov/pubmed/35986374
http://dx.doi.org/10.1186/s13287-022-03112-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389735/
https://www.ncbi.nlm.nih.gov/pubmed/35986374
http://dx.doi.org/10.1186/s13287-022-03112-7

Ejemplares similares